Holen Sie sich die Stockscreener-App
303.28
9.85%
-33.13
Handel nachbörslich:
300.50
-2.78
-0.92%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$336.41
Offen:
$320.37
24-Stunden-Volumen:
13.26M
Relative Volume:
1.38
Marktkapitalisierung:
$379.27B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
57.24
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
-4.68%
1M Leistung:
+9.96%
6M Leistung:
+91.10%
1J Leistung:
+257.18%
1-Tages-Spanne:
$302.74
$323.42
1-Wochen-Bereich:
$302.74
$346.19
52-Wochen-Spanne:
$85.86
$346.19
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
303.28 | 420.70B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,641.74 | 677.36B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
453.01 | 398.33B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
1,929.20 | 278.38B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
357.93 | 63.69B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Vestcor Inc Has $13.51 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
OneAscent Investment Solutions LLC Sells 4,036 Shares of Lam Research Corporation $LRCX - MarketBeat
Trivest Advisors Ltd Purchases 675,000 Shares of Lam Research Corporation $LRCX - MarketBeat
82,757 Shares in Lam Research Corporation $LRCX Acquired by PBU The Pension Fund of Early Childhood & Youth Educators - MarketBeat
Prudential PLC Acquires 16,247 Shares of Lam Research Corporation $LRCX - MarketBeat
111 Capital Has $1.52 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. stock outperforms competitors despite losses on the day - MSN
Lam Research: A Wide-Moat Equipment Leader That I Rate A BuyDespite A Rich Valuation - Seeking Alpha
Lam Research Corp Stock (LRCX) Moved Down by 6.04% on Jun 5: A Full Analysis - TradingKey
Why this $40-billion money manager likes Lam Research and Nvidia but sold Ryder System - The Globe and Mail
Director Trims Ichor Holdings — the Cycle Bet Is What Matters Now - The Motley Fool
Investors love Lam Research stockshorting OTM puts in huge, unusual volume - MSN
Mizuho Raises its Price Target on Lam Research (LRCX) - Insider Monkey
What Do Analysts Say About Lam Research (LRCX)’s Earnings Outlook? - Insider Monkey
Is Wall Street bullish or bearish on Lam Research stock? - MSN
Lam Research slides as chip sector sells off after Broadcom’s results rattle sentiment - Quiver Quantitative
Lam Research Corp Stock (LRCX) Moved Down by 3.97% on Jun 4: Key Drivers Unveiled - TradingKey
LRCX overweight: How Lam Research is poised to outperform the $149B WFE market - MSN
Lam Research Corp (LRCX): Increasing Dependence on Essential Chip Manufacturing - Yahoo Finance
TD Asset Management Inc Sells 852,142 Shares of Lam Research Corporation $LRCX - MarketBeat
4,687 Shares in Lam Research Corporation $LRCX Acquired by Marble Wealth LLC - MarketBeat
Is Lam Research stock outperforming the S&P 500? - MSN
Lam Research Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Will Strong Cash Flows Support Lam Research's Buyback Strategy Ahead? - Yahoo Finance
Lam Research Corporation $LRCX Position Boosted by Westpac Banking Corp - MarketBeat
Westhampton Capital, LLC's Lam Research Corp(LRCX) Holding History - GuruFocus
CIBC Asset Management Inc Increases Stake in Lam Research Corporation $LRCX - MarketBeat
Is Lam Research Corp (LRCX) Overvalued After 5.5% Rally? GF Valu - GuruFocus
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research SVP Neil Fernandes sells $2.37m in shares By Investing.com - Investing.com India
Lam Research SVP Neil Fernandes sells $2.37m in shares - Investing.com
Lam Research Corp at Bank of America Global Technology Conference Transcript - GuruFocus
Lam Research (NASDAQ: LRCX) SVP sells 7,659 shares under 10b5-1 plan - Stock Titan
Lam Research Corp Stock (LRCX) Moved Up by 4.68% on Jun 2: Drivers Behind the Movement - TradingKey
Lam Research stock hits all-time high at 333.44 USD By Investing.com - Investing.com Australia
Lam Research stock hits all-time high at 333.44 USD - Investing.com
Mutual of America Capital Management LLC Reduces Stake in Lam Research Corporation $LRCX - MarketBeat
NYLIM VP MFS Investors Trust Portfolio's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research Corporation $LRCX Shares Purchased by Cercano Management LLC - MarketBeat
3Chopt Investment Partners LLC Buys 3,266 Shares of Lam Research Corporation $LRCX - MarketBeat
LRCX News | LAM RESEARCH CORP (NASDAQ:LRCX) - ChartMill
Lam Research (LRCX) Form 144: 7,659 vested shares listed for resale - Stock Titan
Is Lam Research Stock Outperforming the S&P 500? - Barchart
Top research reports for Philip Morris, Lam Research & Goldman Sachs - MSN
Lam Research CEO Sees AI Fueling $140 Billion Chip Equipment Boom - Yahoo Finance
Eurizon SLJ Capital Ltd Purchases New Stake in Lam Research Corporation $LRCX - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Research Alert: CFRA Maintains Buy Rating On Shares Of Lam Research Corporation - 富途牛牛
Lam Research Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MSN
Lam Research awards $250K investment for Lightfinder’s optical sensing tech - GamesBeat
Lam Research Corp. Hits Day High with 5.68% Surge in Stock Price - Markets Mojo
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
9.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):